Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Cardiopulmonary Resuscitation (CPR) Video to Enhance Advance Care Planning in Advanced Upper Gastrointestinal Cancer Patients
A completed clinical trial evaluating a CPR video to enhance advance care planning in patients with pancreatic and hepatobiliary cancers.
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating vaccine therapy, cyclophosphamide, and cetuximab in metastatic or locally advanced pancreatic cancer has completed …
-
CLINICAL_TRIALS trial_result · 2015-07-15Clinical Trial Update: Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer [Phase 1]
This document notes a Phase 1 clinical trial evaluating the combination of icotinib and gemcitabine as first-line therapy for pancreatic can…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Etomidate vs. Midazolam for Sedation During ERCP [Phase 4]
Phase 4 trial comparing etomidate to midazolam for sedation during ERCP; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating the safety and exploratory efficacy of Kanglaite Injection in pancreatic cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine with Abraxane for potentially operable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating the combination of capecitabine and vorinostat with radiation therapy in nonmetastatic pancreatic cancer has comple…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial of gemcitabine plus pazopanib for metastatic pancreatic cancer has been terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer [Phase 1]
Phase 1 trial evaluating gemcitabine with radiation therapy in locally advanced upper gastrointestinal cancers, including extrahepatic bile …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer [Phase 1]
Results from a Phase I dose-escalation study of VXM01 in patients with locally advanced, inoperable, or Stage IV pancreatic cancer have been…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer [NA]
A completed clinical trial update evaluating whether palliative care improves quality of life for patients with newly diagnosed pancreatic c…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 safety trial of a Cancer Stem Cell Vaccine for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers [Phase 2]
Phase II feasibility study results for the treatment of resected cholangiocarcinoma, gallbladder cancer, pancreatic cancer, and ampullary ca…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery [NA]
Clinical trial update indicating completion of a study on postoperative oral nutritional supplementation after major gastrointestinal surger…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats [Phase 2]
Open-label Phase 2 trial assessing efficacy and safety of olaparib in patients with BRCA1/BRCA2 mutations across ovarian, breast, prostate, …
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of icotinib and gemcitabine as first-line therapy for pancreatic cancer, with status not…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer [NA]
The trial investigating capecitabine with radiation therapy in advanced pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a dose-escalation study of TH-302 in combination with gemcitabine, docetaxel, or pemetr…
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin [Phase 1]
Phase 1 trial update of Gemcitabine in combination with TheraSphere Y-90 for hepatic tumors of pancreatobiliary origin. The study status is …
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial update on IMPRIME PGG with BTH1704 plus gemcitabine for advanced pancreatic cancer; the study NCT02132403 has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update on LMB-9 immunotoxin in patients with advanced solid tumors. The study has completed and includes bladder cancer, breas…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of calcitriol and docetaxel in patients with metastatic or locally advanced pancreat…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated adding metformin hydrochloride to chemotherapy for metastatic pancreatic cancer. The study was terminated.